These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19561646)

  • 1. Functional RET G691S polymorphism in cutaneous malignant melanoma.
    Narita N; Tanemura A; Murali R; Scolyer RA; Huang S; Arigami T; Yanagita S; Chong KK; Thompson JF; Morton DL; Hoon DS
    Oncogene; 2009 Aug; 28(34):3058-68. PubMed ID: 19561646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.
    Barr J; Amato CM; Robinson SE; Kounalakis N; Robinson WA
    Melanoma Res; 2012 Feb; 22(1):92-5. PubMed ID: 22189301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
    Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
    Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
    Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
    Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines.
    Ohshima Y; Yajima I; Takeda K; Iida M; Kumasaka M; Matsumoto Y; Kato M
    PLoS One; 2010 Apr; 5(4):e10279. PubMed ID: 20422010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
    Besset V; Scott RP; Ibáñez CF
    J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Lee RH; Wong WL; Chan CH; Chan SY
    J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
    Jahn SW; Kashofer K; Halbwedl I; Winter G; El-Shabrawi-Caelen L; Mentzel T; Hoefler G; Liegl-Atzwanger B
    Mod Pathol; 2015 Jul; 28(7):895-903. PubMed ID: 25769001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell line-derived neurotrophic factor induces cell proliferation in the mouse urogenital sinus.
    Park HJ; Bolton EC
    Mol Endocrinol; 2015 Feb; 29(2):289-306. PubMed ID: 25549043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
    Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
    Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal.
    Miller DD; Emley A; Yang S; Richards JE; Lee JE; Deng A; Hoang MP; Mahalingam M
    Mod Pathol; 2012 Apr; 25(4):505-15. PubMed ID: 22157936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell-derived neurotrophic factor (GDNF)-induced migration and signal transduction in corneal epithelial cells.
    You L; Ebner S; Kruse FE
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2496-504. PubMed ID: 11581189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophin receptors and perineural invasion in desmoplastic melanoma.
    Frydenlund N; Leone DA; Mitchell B; Yang S; Deng A; Hoang MP; Mahalingam M
    J Am Acad Dermatol; 2015 May; 72(5):851-8. PubMed ID: 25752716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
    Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
    Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
    Jain A; Tripathi R; Turpin CP; Wang C; Plattner R
    Oncogene; 2017 Aug; 36(32):4585-4596. PubMed ID: 28368422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret proto-oncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF).
    Okada Y; Takeyama H; Sato M; Morikawa M; Sobue K; Asai K; Tada T; Kato T; Manabe T
    Int J Cancer; 1999 Mar; 81(1):67-73. PubMed ID: 10077155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Ret knockin mice reveals a critical role for IKKs, but not PI 3-K, in neurotrophic factor-induced survival of sympathetic neurons.
    Encinas M; Rozen EJ; Dolcet X; Jain S; Comella JX; Milbrandt J; Johnson EM
    Cell Death Differ; 2008 Sep; 15(9):1510-21. PubMed ID: 18497757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
    Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
    Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas1 reduces Ret tyrosine 1062 phosphorylation and alters GDNF-mediated intracellular signaling.
    López-Ramírez MA; Domínguez-Monzón G; Vergara P; Segovia J
    Int J Dev Neurosci; 2008 Aug; 26(5):497-503. PubMed ID: 18394855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.